Dihydroisoindolones as allosteric modulators of glucokinase

Details Dihydroisoindolones as allosteric modulators of glucokinase Dihydroisoindolones as allosteric modulators of glucokinase

2011-04-19

2011-04-19

Chandrakumar, Nizal S (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

active

07928246

ABSTRACT:
The present invention relates to compounds of Formula (I),methods for preparing these compounds, compositions, intermediates and derivatives thereof and for treating glucokinase mediated disorders. More particularly, the compounds of the present invention are glucokinase modulators useful for treating disorders including, but not limited to, type II diabetes.

REFERENCES:
patent: 7531671 (2009-05-01), Bian et al.
patent: WO 02/20485 (2002-03-01), None
patent: WO 02/48106 (2002-06-01), None
patent: WO 03/055482 (2003-07-01), None
Efanov et al. Endocrinology, 146(9), 3696-3701.
Fujisawa, G. et. al; “Therapeutic efficacy of non-peptide ADH antagonist OPC-31260 in SIADH rats.”Kidney Intl; vol. 44; 1993; pp. 19-23.
Connolly, H. M. et al; “Valvular Heart Disease Associated with Fenfluramine-Phentermine.”New Eng. J. of Medicine; vol. 337, 1997, No. 9, pp. 581-588.
Lowney, V. K. ObesityDecision Resources Inc. Mosaic Study #20, 2000.
Database Chemcats (online), Chemical Abstract Service, Columbus, Ohio, US. XP002425266 and, “Interchim Intermediates” 2005, Interchim, France.
PCT Search Report No. PCT/US2006/042602 dated Mar. 27, 2007, which relates to U.S. Appl. No. 11/554,523, filed Oct. 30, 2006.

Affiliated with

Also associated with

Rating

Dihydroisoindolones as allosteric modulators of glucokinase does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dihydroisoindolones as allosteric modulators of glucokinase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dihydroisoindolones as allosteric modulators of glucokinase will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2628069